Increased our position in Inari Medical, Inc. due to attractive valuations for a market-leading medical device company. Inari dominates the PE market and has significant growth opportunities in ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Full-year 2024 revenue guidance was increased, reflecting high growth expectations. Inari Medical reported strong revenue growth in its third-quarter 2024 earnings but faced a net loss due to ...
Analysts' ratings for Inari Medical NARI over the last quarter vary from bullish to bearish, as provided by 8 analysts. The table below summarizes their recent ratings, showcasing the evolving ...
Inari Amertron Bhd would prefer to forget its latest financial results, which saw its net profit drop by 7.2% for the financial year ended June 30, 2024. The result may not be alarming but ...
Inari Medical (NASDAQ:NARI) will release its quarterly earnings report on Monday, 2024-10-28. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Inari Medical to ...
PETALING JAYA: Inari Amertron Bhd is anticipating sales growth in financial year 2023 (FY23), despite flattish growth in radio frequency (RF) components. PublicInvest Research said despite seeing ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.